NPY receptors in human cancer: a review of current knowledge

Meike Körner1, Jean Claude Reubi

  • 1Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Murtenstrasse 31, PO Box 62, CH-3010 Bern, Switzerland.

Peptides
|January 16, 2007
PubMed

Insights

Neuropeptide Y (NPY) receptors are over-expressed in several human cancers. Targeting these NPY receptors offers potential for novel cancer diagnostics and therapies.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Peptide hormone receptors are frequently over-expressed in human cancers, presenting opportunities for in vivo tumor targeting.
  • Neuropeptide Y (NPY) receptors represent a novel and promising class of targets for cancer diagnostics and therapeutics.

Purpose of the Study:

  • To investigate the expression and potential utility of NPY receptors (Y1 and Y2) in various human cancers.
  • To explore the pathophysiological role and clinical applications of tumoral NPY receptors.

Main Methods:

  • In vitro receptor autoradiography was employed to detect Y1 and Y2 receptor expression.
  • Analysis included breast carcinomas, adrenal gland tumors, renal cell carcinomas, and ovarian cancers.

Main Results:

  • Y1 and Y2 NPY receptors were found to be expressed in tumor cells and associated blood vessels of the studied cancers.
  • Tumoral NPY receptors may be activated by endogenous NPY, influencing tumor cell proliferation and blood supply.

Conclusions:

  • Over-expressed NPY receptors in tumors provide a basis for developing new diagnostic and therapeutic strategies.
  • Targeting tumoral NPY receptors with NPY analogs could enable scintigraphic tumor imaging and therapeutic interventions.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...